SEARCH

SEARCH BY CITATION

References

  • Abacassamo F, Enosse S, Aponte JJ et al. (2004) Efficacy of chloroquine, amodiaquine, sulphadoxine–pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria. Tropical Medicine and International Health 9, 200208.
  • Adjuik M, Agnamey P, Babiker A et al. (2002) Amodiaquine–artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet 359, 13651372.
  • Ashley EA, McGready R, Hutagalung R et al. (2005) A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin–piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria. Clinical Infectious Disease 41, 425432.
  • Ashley EA, Lwin KM, McGready R et al. (2006a) An open label randomized comparison of mefloquine–artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. Tropical Medicine and International Health 11, 16531660.
  • Ashley EA, Stepniewska K, Lindegardh N et al. (2006b) Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria. Antimicrobial Agents Chemotherapy 50, 22812285.
  • Denis MB, Davis TM, Hewitt S et al. (2002) Efficacy and safety of dihydroartemisinin–piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria. Clinical Infectious Disease 35, 14691476.
  • Denis MB, Tsuyuoka R, Poravuth Y et al. (2006) Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia. Tropical Medicine and International Health 11, 13601366.
  • Erhart A, Ngo DT, Phan VK et al. (2005) Epidemiology of forest malaria in central Vietnam: a large scale cross-sectional survey. Malaria Journal 4, 58.
  • Giao PT, De Vries PJ, Hung le Q, Binh TQ, Nam NV & Kager PA (2004) CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone–proguanil against falciparum malaria in Vietnam. Tropical Medicine and International Health 9, 209216.
  • Grande T, Bernasconi A, Erhart A et al. (2007) A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru. PLoS ONE 2, e1101.
  • Grandesso F, Bachy C, Donam I et al. (2006) Efficacy of chloroquine, sulfadoxine–pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria among children under five in Bongor and Koumra, Chad. Trans R Society Tropical Medicine and Hygiene 100, 419426.
  • Guthmann JP, Ampuero J, Fortes F et al. (2005) Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine–pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine–pyrimethamine + artesunate in Huambo and Bie provinces, central Angola. Trans R Society Tropical Medicine and Hygiene 99, 485492.
  • Hasugian AR, Purba HL, Kenangalem E et al. (2007) Dihydroartemisinin–piperaquine versus artesunate–amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria. Clinical Infectious Disease 44, 10671074.
  • Hombhanje FW, Hwaihwanje I, Tsukahara T et al. (2005) The disposition of oral amodiaquine in Papua New Guinean children with falciparum malaria. British Journal of Clinical Pharmacology 59, 298301.
  • Hung TY, Davis TM, Ilett KF et al. (2004) Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria. British Journal of Clinical Pharmacology 57, 253262.
  • Janssens B, Van Herp M, Goubert L et al. (2007) A randomized open study to assess the efficacy and tolerability of dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia. Tropical Medicine and International Health 12, 251259.
  • Karema C, Fanello CI, Van Overmeir C et al. (2006) Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children. Transactions of the Royal Society of Tropical Medicine and Hygiene 100, 11051111.
  • Karunajeewa H, Lim C, Hung TY et al. (2004) Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria. British Journal of Clinical Pharmacology 57, 9399.
  • Krudsood S, Tangpukdee N, Thanchatwet V et al. (2007) Dose ranging studies of new artemisinin–piperaquine fixed combinations compared to standard regimens of artemisisnin combination therapies for acute uncomplicated falciparum malaria. Southeast Asian Journal of Tropical Medicine Public Health 38, 971978.
  • Luzzi GA & Peto TE (1993) Adverse effects of antimalarials. An update. Drug Safety 8, 295311.
  • Maguire JD, Krisin, Marwoto H, Richie TL, Fryauff DJ & Baird JK (2006) Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia. Clinical Infectious Disease 42, 10671072.
  • Morillon M, Baudon D & Dai B (1996) Malaria in Vietnam in 1996: brief synthesis of epidemiological data. Medicine Trop (Mars) 56, 197200.
  • Mutabingwa TK, Anthony D, Heller A et al. (2005) Amodiaquine alone, amodiaquine + sulfadoxine–pyrimethamine, amodiaquine + artesunate, and artemether–lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet 365, 14741480.
  • Myint HY, Ashley EA, Day NP, Nosten F & White NJ (2007) Efficacy and safety of dihydroartemisinin–piperaquine. Trans R Society Tropical Medicine and Hygiene 101, 858866.
  • Nosten F & White NJ (2007) Artemisinin-based combination treatment of falciparum malaria. American Journal of Tropical Medicine and Hygiene 77, 181192.
  • Nosten F, Luxemburger C, Ter Kuile FO et al. (1994) Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate–mefloquine combination. Journal of Infectious Disease 170, 971977.
  • Olliaro P, Nevill C, LeBras J et al. (1996) Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet 348, 11961201.
  • Padley D, Moody AH, Chiodini PL & Saldanha J (2003) Use of a rapid, single-round, multiplex PCR to detect malarial parasites and identify the species present. Annals of Tropical Medicine and Parasitology 97, 131137.
  • Palmer KJ, Holliday SM & Brogden RN (1993) Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 45, 430475.
  • Price RN, Hasugian AR, Ratcliff A et al. (2007) Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin–piperaquine for drug-resistant malaria. Antimicrobial Agents and Chemotherapy 51, 40904097.
  • Ratcliff A, Siswantoro H, Kenangalem E et al. (2007a) Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet 369, 757765.
  • Ratcliff A, Siswantoro H, Kenangalem E et al. (2007b) Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine–pyrimethamine in southern Papua, Indonesia. Transactions of the Royal Society of Tropical Medicine and Hygiene 101, 351359.
  • Sanh NH, Van Dung N, Thanh NX, Trung TN, Van Co T & Cooper RD (2008) Forest malaria in central Vietnam. American Journal of Tropical Medicine and Hygiene 79, 652654.
  • Silachamroon U, Krudsood S, Thanachartwet W et al. (2005) An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria. Southeast Asian Journal of Tropical Medicine and Public Health 36, 591596.
  • Smithuis F, Kyaw MK, Phe O et al. (2006) Efficacy and effectiveness of dihydroartemisinin–piperaquine versus artesunate–mefloquine in falciparum malaria: an open-label randomised comparison. Lancet 367, 20752085.
  • Sowunmi A, Fehintola FA, Adedeji AA et al. (2005) Open randomized study of artesunate–amodiaquine vs. chloroquine–pyrimethamine–sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children. Tropical Medicine and International Health 10, 11611170.
  • Tarning J, Ashley EA, Lindegardh N et al. (2008) Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin–piperaquine in patients with Plasmodium falciparum malaria in Thailand. Antimicrobial Agents and Chemotherapy 52, 10521061.
  • Tran TH, Dolecek C, Pham PM et al. (2004) Dihydroartemisinin–piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial. Lancet 363, 1822.
  • Vijaykadga S, Rojanawatsirivej C, Cholpol S, Phoungmanee D, Nakavej A & Wongsrichanalai C (2006) In vivo sensitivity monitoring of mefloquine monotherapy and artesunate–mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Tropical Medicine and International Health 11, 211219.
  • Watkins WM, Sixsmith DG, Spencer HC et al. (1984) Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya. Lancet 1, 357359.
  • White NJ (2006) Malaria—time to act. New England Journal of Medicine 355, 19561957.
  • WHO (2001). The Use of Antimalarial Drugs: Report of an Informal Consultation. (WHO/CDS/RBM/2001.33.), p.141, WHO, Geneva.
  • Yeung S, Pongtavornpinyo W, Hastings IM, Mills AJ & White NJ (2004) Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices. American Journal of Tropical Medicine and Hygiene 71, 179186.